On February 21, 2022, a lecture by Alexei Vinogradov was held at the master's program "Bioeconomics" as part of the course "Design, organization and management of biotechnological production".
As part of his lecture, Alexei Vinogradov told the students about the venture business and investments in innovative medical research. As part of the lecture, possible questions were raised: what is venture financing, what are the reasons for startups to receive capital from venture capital cases in the field of biotech and pharmaceuticals, in particular; what are the risks from the start-up and from the side of infection; how, without a patent, you can secure your development; what is "orphan status" and "protection of exclusivity"; how is the consideration and selection of projects for venture financing; how financial modeling is built and financial risks are calculated, etc.
As part of his lecture, Alexei Vinogradov told the students about the venture business and investments in innovative medical research. As part of the lecture, possible questions were raised: what is venture financing, what are the reasons for startups to receive capital from venture capital cases in the field of biotech and pharmaceuticals, in particular; what are the risks from the start-up and from the side of infection; how, without a patent, you can secure your development; what is "orphan status" and "protection of exclusivity"; how is the consideration and selection of projects for venture financing; how financial modeling is built and financial risks are calculated, etc.